medium
Sell
70,000 shares
$1,740,200
Significance
6/10
CPRX CEO Daly sells 70,000 shares at $24.86 for $1.7M; retains 199,764 shares post-sale
Richard J Daly, President and CEO of Catalyst Pharmaceuticals, sold 70,000 shares (25.9% of his pre-transaction holdings) at $24.86 on 2025-05-30 for $1,740,200.00. The company's fundamentals remain robust with Revenue of $141,421,000.00 in the latest quarter, net income of $56,737,000.00, a P/E of 15.38, and annual revenue growth of +23.5%. The sale occurs near the 52-week high ($25.74), with the stock currently trading at $24.91. Despite the significant share reduction, the CEO retains 199,764 shares, maintaining substantial residual ownership and alignment with shareholders.